Lipid Metabolism and Diabetes

Patients with diabetes often show abnormal lipid profiles because insulin regulates several of the steps of lipid metabolism. Patients with type 1 diabetes that exhibit effective glycaemic control may exhibit qualitative abnormalities. Dyslipidaemia in type2 diabetes is characterised by several strictly linked abnormalities: elevated fasting and postprandial triglycerides, a significant decrease in high‐density lipoprotein (HDL) cholesterol and an increase in smaller low‐density lipoprotein (LDL) and HDL particles. Also, the elevated postprandial triglycerides that are often present in patients with type2 diabetes may be linked to insulin resistance. Therefore, the abatement of hyperglycaemia and insulin resistance should be one of the main treatment objectives to address dyslipidaemia in patients with diabetes.

 

  • Lipid metabolism and hyperglycemia
  • Risk factors for lung cancer
  • Lipid metabolism in type 2 diabetes
  • Lipid metabolism in type 1 diabetes
  • Dyslipidemia
  • Lipid metabolism in cancer metastasis

Related Conference of Lipid Metabolism and Diabetes

September 28-29, 2018

2nd International Conference on Diabetes and Diabetic Nursing Care

Montreal, Quebec, Canada
November 21-22, 2018

14th World Congress on Endocrinology & Diabetes

Paris, France
November 26-27, 2018

26th International Diabetes and Healthcare Conference

Helsinki, Finland
November 26-27, 2018

13th European Diabetes and Endocrinology Congress

Dublin, Ireland

March 28-29, 2019

21st Asia Pacific Diabetes Conference

Osaka,Japan
May 16-17, 2019

2nd Global Meeting on Diabetes and Endocrinology

Abu Dhabi, UAE

28th European Diabetes Congress

June 10-11, 2019 | Edinburgh, Scotland
July 24-25, 2019

29th World Diabetes & Heart Congress

Melbourne, Australia
Oct 03-04, 2019

Euro Diabetes Congress & Expo

| Paris, France

Lipid Metabolism and Diabetes Conference Speakers

Recommended Sessions

Related Journals

Are you interested in